Histone deacetylase inhibitors

Details Histone deacetylase inhibitors Histone deacetylase inhibitors

A - Human Necessities

61

K

A61K 31/19 (2006.01)

Patent

CA 2587013

Hormone refractory metastatic disease can be treated with an oxyamide- containing compound through the inhibition of HDAC1 or HDAC2.

La maladie métastatique réfractaire hormonale peut être traitée au moyen d'un composé contenant de l'oxyamide par inhibition de HDAC1 ou HDAC2.

Affiliated with

Also associated with

Rating

Histone deacetylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Histone deacetylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histone deacetylase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1694235